Abstract
Background. The aim of this study was to evaluate the clinicopathologic characteristics of patients
with hepatocellular carcinoma (HCC) and bile duct thrombi (BDT). Patients. Seventeen patients with HCC and BDT among 671 patients with HCC who underwent hepatic
resection were enrolled in this study. Results. There were no significant differences in the survival rates between patients with
and those without BDT, although the rate of stage IV or portal vein invasion was significantly
higher in patients with HCC and BDT than in those with HCC but without BDT. In 9 of
17 patients with BDT, preoperative jaundice was observed. Five of the 17 patients
underwent a bile duct resection combined with hepatic resection, and 12 patients underwent
hepatic resection with removal of the BDT without bile duct resection. None of the
patients had histopathologic evidence of direct tumor invasion into the bile duct
wall or of any tumor recurrence related to the BDT. There were no significant differences
in the survival rates between patients who underwent bile duct resection and those
who did not. Conclusion. Hepatic resection and the removal of BDT without bile duct resection were sufficient
surgical interventions to treat patients with HCC and BDT. (Surgery 2000;127:779-83.)
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy.Ann Surg. 1998; 227: 433-439
- Case records of the Massachusetts General Hospital.N Engl J Med. 1947; 237 (Case 33441): 673-676
- Icteric type hepatoma.Med Chir Dig. 1975; 4: 267-270
- Hepatocellular carcinoma presenting as intrabile duct tumor growth.Cancer. 1982; 49: 2144-2147
- Hepatoma with obstructive jaundice due to the migration of a tumor mass in the biliary tract: report of a successful resection.Surgery. 1979; 85: 593-598
- Common bile duct obstruction by hepatoma.Am J Surg. 1977; 133: 233-235
- Surgery for biliary obstruction by tumor thrombus in primary liver cancer.Br J Surg. 1996; 83: 1522-1525
- Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi.Hepatogastroenterology. 1994; 41: 349-354
- Classification of primary liver cancer.First English ed. Kanehara & Co, Ltd, Tokyo1997
- M. Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein.World J Surg. 1992; 16: 1172-1176
- Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma.Am J Gastroenterol. 1997; 92: 2257-2259
- Choledochojejunostomy: possible risk factor for septic complications after percutaneous hepatic tumor ablation.AJR Am J Roentgenol. 2000; 174: 985-986
Article info
Publication history
Accepted:
May 14,
2000
Footnotes
*Supported in part by grants from the Scientific Research Fund of the Ministry of Education, Science, Sports, and Culture of Japan.
**Reprint requests: Iwao Ikai, MD, Department of Gastroenterological Surgery, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto. 606-8507, Japan.
★Surgery 2000;127:779-83.
Identification
Copyright
© 2000 Mosby, Inc. Published by Elsevier Inc. All rights reserved.
